Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.
David
D
de Lucena
Brisa Simões
BS
Fernandes
Mauricio
M
Kunz
Gabriel Rodrigo
GR
Fries
Laura
L
Stertz
Bianca
B
Aguiar
Bianca
B
Pfaffenseller
Clarissa Severino
CS
Gama
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood*; D003024:Clozapine / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D019208:Brain-Derived Neurotrophic Factor; D015259:Dopamine Agents; D003024:Clozapine; D008559:Memantine